Why Ozempic Doesn't Work for Everyone - Your DNA Already Knows

Ben Synth explores why 14-15% of people taking GLP-1 drugs like Ozempic see no weight loss despite weekly injections. The episode examines pharmacogenomics research revealing how genetic variants in the GLP-1 receptor gene and other DNA factors may predetermine drug effectiveness before treatment even begins, and discusses emerging genetic testing that could revolutionize personalized obesity treatment.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.